Influence of compliance patients with a combination of type 2 diabetes and chronic gastritis on features of course and treatment
DOI:
https://doi.org/10.26641/2307-0404.2018.3(part1).142376Keywords:
chronic gastritis, type 2 diabetes mellitus, complianceAbstract
Diabetes mellitus is a systemic metabolic disease that can affect most of the bodily systems, including the gastrointestinal tract. Some studies report a higher prevalence of HP infection in people with diabetes. A healthy diet, regular physical activity, support of normal body weight and avoiding tobacco use can help prevent or delay the onset of DM 2 type. The purpose of the study - to evaluate the peculiarities of the clinical course and effectiveness of treatment of DM type 2 and chronic gastritis (CG) depending on the presence of higher education in patients. 46 HP positive patients with a combination of CG and type 2 DM were examined, the average age of patients was 55.4±1.3 years. Patients were divided into 2 groups, depending on the presence or absence of higher education, so that 23 (50%) patients with higher education were included in group I, whereas in the II group – 23 (50%) patients with secondary education. The Morisky-Green scale was tested to determine the patient's compliance. Results. Insulin resistance depends on the presence of HP in the body and its eradication subsequently leads to an improvement in insulin sensitivity. According to the results obtained, patients in group I (with higher education) have a higher degree of adherence to treatment, namely, the average score of compliance in the I group was 0.61±0.15 points, and in the II group – 2.74±0.24 points. Hence, the presence of higher education in a patient contributes to better adherence to treatment. Improvement of insulin resistance after eradication of HP in patients with type 2 DM and CG, and these changes are somewhat more significant in patients with higher education.
References
Leonardo HE, Rocco M, Zagari, Franco B. Epidemiology of Helicobacter pylori Infection. J Helicobacter. 2014;1(19):1-5.
International Diabetes Federation. 2013 Sixth edition. Available from: https://www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdf. Accessed 19 Feb 2016.
Sonnenberg A. Review article: historic changes of Helicobacter pylori-associated diseases. Aliment Pharmacol Ther. 2013;38:329-42.
Devrajani BR, Shah SZ, Soomro AA, Devrajani T. Type 2 diabetes mellitus: a risk factor for Helicobacter pylori infection: a hospital based case-control study. Int J Diabetes Dev Countries 2010;30:22-6.
WHO. Fact sheet no. 312: Diabetes. Geneva, WHO; 2013.
World Health Organization. Global Health Estimates: Deaths by Cause, Age, Sex and Country, 2000-2012. Geneva, WHO; 2014.
Downloads
How to Cite
Issue
Section
License
Copyright (c) 2018 Medicni perspektivi (Medical perspectives)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
